Cabazitaxel

Nat Rev Drug Discov. 2010 Sep;9(9):677-8. doi: 10.1038/nrd3254.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Clinical Trials as Topic
  • Drug Approval
  • Drug Discovery
  • Humans
  • Male
  • Prednisone / administration & dosage
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / physiopathology
  • Taxoids / administration & dosage
  • United States
  • United States Food and Drug Administration

Substances

  • Taxoids
  • cabazitaxel
  • Prednisone